Bar-Ilan University

Allot Announces the Appointment of Eyal Harari as Chief Executive Officer

Retrieved on: 
Montag, Mai 6, 2024
RadCom, Bar-Ilan University, Computer science, Business administration, Corporate law, Radcom Ltd, Open University, Growth

Hod Hasharon, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, today announced the appointment of Eyal Harari as its Chief Executive Officer effective May 6, 2024.

Key Points: 
  • Hod Hasharon, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, today announced the appointment of Eyal Harari as its Chief Executive Officer effective May 6, 2024.
  • “We are extremely pleased that Eyal is joining Allot as Chief Executive Officer.
  • Prior to joining Allot, between November 2019 and January 2024, Mr. Harari served as Chief Executive Officer of Radcom Ltd., a NASDAQ listed company and a leader in providing automated service assurance solutions for telecom operators running 5G/4G networks.
  • "I am thrilled with the opportunity to join Allot“, said Mr. Harari.

SwiftDuct Presents Positive Clinical Study Results of SwiftGlide For ERCP Procedures at ESGE Days 2024

Retrieved on: 
Donnerstag, Mai 2, 2024
Electrochemistry, Dielectric spectroscopy, Bar-Ilan University, Poster, Gastrointestinal Endoscopy, Trial of the century, ESGE, Fluoroscopy, Bile, Pancreatic duct, Patient, EMMS Nazareth Hospital, Pancreatitis, Galilee Medical Center, Assistant, ERCP, Clinical trial, Medical imaging

SAKHNIN, Israel, May 2, 2024 /PRNewswire/ -- In a poster presentation at the 2024 annual meeting of the European Society of Gastrointestinal Endoscopy, ESGE Days 2024, SwiftDuct announced the positive findings of the first clinical trial of SwiftGlide™, the company's electrochemical navigation system for ERCP procedures.

Key Points: 
  • SwiftDuct's first clinical study, which was conducted at Galilee Medical Center, demonstrates that the company's electrochemical navigation method has the potential to improve ERCP procedures and outcomes, marking an important milestone towards Fluoroscopy-Free ERCP cannulation.
  • ERCP is a widely used procedure to diagnose and treat issues in the bile or pancreatic ducts.
  • SAKHNIN, Israel, May 2, 2024 /PRNewswire/ -- In a poster presentation at the 2024 annual meeting of the European Society of Gastrointestinal Endoscopy, ESGE Days 2024 , SwiftDuct announced the positive findings of the first clinical trial of SwiftGlide™, the company's electrochemical navigation system for ERCP procedures.
  • The study showed that SwiftGlide™ was successful in differentiating between bile and pancreatic/mixed juices as the basis to providing selective and safe biliary cannulation during ERCP procedures.

Nano Dimension Refreshes Corporate Governance by Appointing Major General (Ret.) Eitan Ben-Eliahu to the Company’s Board of Directors

Retrieved on: 
Dienstag, April 16, 2024
RET, Aeronautics, Law, Bar-Ilan University, IAF, Tel Aviv Stock Exchange, Policy, Squadron, Yom Kippur War, 3D, 3D printing, Commander, Tel Aviv University, Television, AMP, Electronics, Advanced Management Program, Ethics, Open University, Harvard University, Major general, Management

Waltham, Mass, April 16, 2024 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printing solutions, today announced that Major General (Ret.) Eitan Ben-Eliahu is joining its Board of Directors (the “Board”).

Key Points: 
  • Eitan Ben-Eliahu is joining its Board of Directors (the “Board”).
  • During his long business career until his current appointments, Major General (Ret.)
  • Simon Fried, a co-founder of Nano Dimension, will step down from his position as a director after over 10 years with the Company.
  • Dr. Yoav Nissan-Cohen, Chairman, and Yoav Stern, CEO and member of the Board, of Nano Dimension issued a joint statement: “We are honored to add Major General (Ret.)

Mission Bio's New Translocation Analysis Offers Insights into Critical Safety Assessment for Gene-Edited Cell Products

Retrieved on: 
Donnerstag, April 25, 2024
Biotechnology, Pharmaceutical, General Health, Health, Hospitals, Genetics, Clinical Trials, Other Health, Annual, Cancer, Bar-Ilan University, CRISPR, Hope, Safety, DSM-IV codes, Chromosomal translocation, Doctor of Philosophy, Cell, Mission, DNA, Therapy, B cell, Product management, Patient, Principal, Gene, Chromosome, Society, Genome, Immune system, Medicine, Vaccine

Measuring predicted translocations along with on- and off-target editing at single-cell resolution can enable developers to design more efficient and safer therapeutics.

Key Points: 
  • Measuring predicted translocations along with on- and off-target editing at single-cell resolution can enable developers to design more efficient and safer therapeutics.
  • “Conventional bulk methods for detecting chromosomal rearrangements are limited in scale and accuracy,” said Vanee Pho, PhD, Senior Director of Product Management, Cell and Gene Therapy at Mission Bio.
  • “Through our single-cell Tapestri Platform, our latest translocation analysis provides our customers with a comprehensive picture of gene edits and unwanted chromosomal aberrations at single-cell resolution — enabling critical safety assessment of these innovative therapies.
  • “With Mission Bio’s translocation approach, we can profile off-target activity and genome-editing efficiency more robustly and with unparalleled precision.

RAAAM Memory Technologies Closes $4M Seed Round to Commercialize Super Cost Effective On-Chip Memory Solutions

Retrieved on: 
Montag, April 15, 2024
Technology, Hardware, Semiconductor, Bar-Ilan University, SRAM, Doctor of Philosophy, SOC, CMOS, Fin field-effect transistor, Silicon, Research, Artificial intelligence, EPFL, VLSI, Machine learning, CIO, FD-SOI, Swiss

RAAAM Memory Technologies, a start-up company that invented a groundbreaking solution to implement on-chip memory, announced today that it has completed a Seed financing round of $4 million.

Key Points: 
  • RAAAM Memory Technologies, a start-up company that invented a groundbreaking solution to implement on-chip memory, announced today that it has completed a Seed financing round of $4 million.
  • Investors include Serpentine Ventures, J-Ventures, HackCapital, Silicon Catalyst Angels, Claves Investments and large multi-national semiconductor company as a strategic investor.
  • However, the industry standard Static Random Access Memory (SRAM) technology is very area-inefficient and has been facing major scaling difficulties in modern process technologies below 10nm.
  • “RAAAM’s Gain-Cell Random Access Memory (GCRAM) technology is a unique on-chip memory solution that only requires 3 transistors to store a bit of data, as opposed to 6-8 transistors needed for the existing SRAM-based highest-density memory technology.

Yeshiva University Launches Accelerated Transfer Initiative for Students Who Feel Threatened at Current Universities

Retrieved on: 
Donnerstag, April 25, 2024
Education, Bar-Ilan University, Part, Sadness, Provost, Safety, Yeshiva University, Jewish University, Partnership, Growth, NYU, University, Shock, Tel Aviv University, YU, Faculty, Student, Nursing

NEW YORK, April 25, 2024 /PRNewswire/ -- Yeshiva University, the nation's flagship Jewish University for over 140 years, today announced that in light of ongoing antisemitism and harassment on college campuses, YU is reopening its transfer portal for undergraduate applicants, including its Honors program, through May 31st, 2024. The 2024-2025 admissions cycle was already closed and has seen students choosing YU over other elite institutions. This trend is expected to continue among transfers.

Key Points: 
  • The 2024-2025 admissions cycle was already closed and has seen students choosing YU over other elite institutions.
  • As YU expands, the university is creating new faculty positions in a number of fields.
  • In connection with today's announcement, Rabbi Dr. Ari Berman, President of Yeshiva University, issued the following open letter.
  • We extend our hand to be of any assistance in supporting efforts by these universities to protect their students from threats to their safety.

ADAMA Appoints Two New Management Members: Florian Wagner to EVP Portfolio and Innovation; Ruthie Zeltzer to EVP People

Retrieved on: 
Mittwoch, März 27, 2024
Innovation, Growth, Georgia Tech, EVP, Environment, Criminology, Executive, Strategic planning, University, Bar-Ilan University, Schering-Plough, Organizational culture, Senior, IDR, Industrial engineering, Crop protection, Workplace, Marketing, TEL, Merck Group, Management

Florian Wagner will lead the end-to-end management of ADAMA's portfolio lifecycle, accelerating and refining innovation processes.

Key Points: 
  • Florian Wagner will lead the end-to-end management of ADAMA's portfolio lifecycle, accelerating and refining innovation processes.
  • Ruthie Zeltzer takes on the responsibility of fortifying ADAMA's organizational culture, ensuring its resilience amidst the evolving crop protection industry.
  • Steve Hawkins, President and CEO of ADAMA: "I am happy to extend a warm welcome to Florian and Ruthie as they join the Global ADAMA Leadership Team.
  • "The creation of a new Portfolio and Innovation division, that will be led by Florian, encompasses the end-to-end management of ADAMA's portfolio lifecycle.

Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals

Retrieved on: 
Mittwoch, Februar 28, 2024
Infection, Therapy, Bangladesh Technical Education Board, Parity, AFRRI, USUHS, Cocaine, Medicine, NIAID, NIH, Bar-Ilan University, PLUR, World War II, FDA, PLX, Partnership, 3D, Food, Ageing, GMP, Hope, BIRAD, Plural, Meat, Risk, Outline of health sciences, CDMO, Climate, Climate change, Health, Water, Food and Drug Administration, Coffee, Knowledge, Agriculture, Food security, Negotiation, Good manufacturing practice, Pharmaceutical industry

Leveraging our proprietary 3D technology platform, our new vertical PluriAgtech can create high-quality cell-based coffee with 98% less water than traditional coffee production.

Key Points: 
  • Leveraging our proprietary 3D technology platform, our new vertical PluriAgtech can create high-quality cell-based coffee with 98% less water than traditional coffee production.
  • We also estimate that our innovative new production process will reduce the amount of growing area by 95%, potentially preventing deforestation.
  • By creating novel cell-based products both independently and through partnerships, Pluri is showing what’s possible when we all work together.
  • As such, our transformative technology is not only creating long-term value for our shareholders; it’s also making the world a better place.

Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center

Retrieved on: 
Donnerstag, Februar 1, 2024
Cocaine, Gonda, Research, Therapy, CWY, Bar-Ilan University, Addiction, MEAI, Animal, Crave, BIRAD, Pharmaceutical industry

Tel Aviv, Israel / Vancouver, Canada, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the signing of an exclusive long-term license agreement with BIRAD, a research & development company of Bar-Ilan University, to use the joint patent it has with BIRAD for innovative cocaine treatment.

Key Points: 
  • Millions are affected by cocaine addiction worldwide, and the successful application of MEAI [5-Methoxy-2-aminoindane] could revolutionize treatment protocols and offer new hope to those trapped in the cycle of addiction.
  • The trial was designed according to the self-administration paradigm, which is the gold-standard model for examining drug addiction and is based on operant conditioning.
  • Animals previously conditioned with cocaine, received either cocaine (at 15mg/kg) or MEAI at doses of 2.5, 5, 10 and 20 mg/kg.
  • This research also demonstrated MEAI’s unique ability to treat cocaine addiction and its potential to become, if approved by regulatory agencies, the first dedicated cocaine addiction treatment.

Sativus Tech Appoints Financial Leader as New CFO to Drive Growth and Innovation

Retrieved on: 
Mittwoch, Januar 24, 2024
Accounting, CFO, Controlled-environment agriculture, Initial public offering, CPA, MBA, OTC, B2B, Bar-Ilan University, CEA, Growth, Spice

Ben-Or will be responsible for Sativus Tech’s financial strategies as the company prepares to enter the B2B market.

Key Points: 
  • Ben-Or will be responsible for Sativus Tech’s financial strategies as the company prepares to enter the B2B market.
  • Saffron Tech, Sativus Tech subsidiary, utilizes its advanced R&D cultivation technology within a Controlled Environment Agriculture (CEA) system, ensuring consistent, year-round high-quality saffron production.
  • “Uri is an accomplished CFO and business executive who has successfully led several publicly traded companies towards profitable growth,” said Tal Wilk Glazer, CEO of Sativus Tech.
  • “I look forward to working together with my board colleagues and the entire Saffron Tech team as we confront a competitive marketplace.”